Southeast Xlerator Network
Southeast Xlerator Network
批准号:
10004685
负责人:
Eugene Krentsel
金额:
$146.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2022-08-31
关键词:
AccelerationAddressAdoptedAdvocateAstronomyAwardBasic ScienceBiological SciencesBiomedical TechnologyBusinessesCapitalDevelopmentEconomic DevelopmentEcosystemEducationElectronicsEntrepreneurshipEvaluationFacultyFosteringFundingGoalsGrantHealth SciencesHealthcareIncubatorsIndustryInstitutionIntellectual PropertyKentuckyKnowledgeLeadershipLearningLegal patentLicensingMedical DeviceMedical TechnologyMentorsOutcomePathway interactionsPharmacologic SubstancePhasePrivatizationProcessPuerto RicoResearchResourcesServicesSmall Business Innovation Research GrantSmall Business Technology Transfer ResearchStructureSurvival RateTalentsTechniquesTechnologyTechnology TransferTrainers TrainingTrainingTraining ProgramsTraining and EducationUnited States National Institutes of HealthUniversitiesVisionWest Virginiacommercializationdesigneducation resourcesexhaustionexperienceimprovedinnovationinter-institutionaloperationproduct developmentprogramspublic-private partnershipsuccesstechnology developmenttool
中文摘要
东南Xlerator网络建议创建一个联网的、易于访问的区域
技术转让加速中心(“Xlerator中心”或“中心”),以分享最佳实践,
传播教育内容,提供产品、服务、设施等资源
通过实体和在线平台为东南部的创新者和实习生提供连接
理念陈述。由XLerateHealth,LLC领导,XLerateHealth,LLC是SBA获奖的专注于医疗保健的技术
加速器,The Hub将通过以下方式弥合伟大创意和市场之间的鸿沟
利用和连接所有参与人员的现有资源和独特的专业知识资产
东南部理想州地区的实体,2)填补构成高效壁垒的空白
合作机构之间的商业化,以及3)提供必要的资源、教育、
以及商业网络,以促进和维持整个区域的创业文化。这
该项目将解决以下方面的重大差距和缺乏资源、人才和资金
普及生物医学技术的各自地方商业化生态系统
在整个东南部IDEA州地区,使技术转让和
这一地区学术研究成果的商业化程度并不理想。The Hub
目标/核心职能包括:
1.提高创新者对技术如何发展的知识和理解
推向市场。
2.提高加速器和技术转让办公室的知识和理解
关于各种生物医学技术独特的商业化路径
3.便利获取技术/产品开发和商业化资源
早期技术进步和后期产品开发所需
帮助缩小基础研究发现和科学研究发现之间的资金缺口(S)
可行性的证明,以及(B)在赠款资金和私人资本耗尽之间
产生产品和收入所必需的。
5.将药品、医疗器械、医疗保健和IT领域的新创新商业化
电子和其他生物医学技术,通过创业、许可和
与老牌公司建立合作伙伴关系,并将中心的
通过其他地区访问的平台、计划和材料。
Hub的影响将是更多的市场准备好的技术和专利,更成功
初创企业,以及加快生物医学技术加速。
英文摘要
The Southeast XLerator Network proposes to create a networked and easily accessible regional
technology transfer accelerator hub (“XLerator Hub” or “Hub”) to share best practices,
disseminate education content, and offer products, services, facilities and other resources
connected through both physical and online platforms for innovators and trainees in the Southeast
IDeA states. Led by XLerateHealth, LLC, an SBA award-winning healthcare-focused technology
accelerator, the Hub will 1) bridge the divide between great ideas and the marketplace by
leveraging and connecting existing resources and unique expertise assets across all participating
entities in the Southeast IDeA state region, 2) fill the gaps that constitute barriers to efficient
commercialization among partner institutions, and 3) deliver the necessary resources, education,
and business networks to foster and sustain a culture of entrepreneurship across the region. This
project will address significant disparities and lack of access to resources, talent and capital in
respective local commercialization ecosystems for biomedical technologies that are pervasive
across the Southeast IDeA state region, making the rates of technology transfer and
commercialization of academic research discoveries in this region suboptimal. The Hub
objectives/ core functions are:
1. To improve knowledge and understanding by innovators about how technologies are
brought to market.
2. To improve knowledge and understanding by accelerators and technology transfer offices
about the unique commercialization pathways of various biomedical technologies
3. To facilitate access to technology/product development and commercialization resources
required for early-stage technology advancement and later-stage product development
4. To help close the gap(s) in funding (a) between basic research discoveries and scientific
proof of feasibility, and (b) between exhaustion of grant funding and private capital
required to generate products and revenues.
5. To commercialize new innovation in pharmaceuticals, medical devices, healthcare IT and
electronics, and other biomedical technologies through entrepreneurship, licensing and
partnerships with established companies, and additionally commercialize the Hub’s
platform, programs, and materials through access by other regions.
The impact of the Hub will be increased market-ready technologies and patents, more successful
startups, and increased biomedical technology acceleration.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Characterization and Optimization of Injectable In Situ Crosslinked Chitosan-Genipin Hydrogels.
可注射原位交联壳聚糖-京尼平水凝胶的表征和优化。
DOI:
10.1002/mabi.202200505
发表时间:
2023
期刊:
Macromolecular bioscience
影响因子:
4.6
作者:
[Priddy-Arrington,TylerR, Edwards,ReaganE, Colley,ClaireE, Nguyen,MarissaM, Hamilton-Adaire,Tess, Caldorera-Moore,MaryE]
通讯作者:
Caldorera-Moore,MaryE
DOI:
10.3390/ijms22073752
发表时间:
2021-04-04
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Ye Q, Mohamed R, Dakhlallah D, Gencheva M, Hu G, Pearce MC, Kolluri SK, Marsh CB, Eubank TD, Ivanov AV, Guo NL]
通讯作者:
Guo NL
I-RED Southeast XLerator Network
-
批准号:10779668
-
项目类别:
-
资助金额:$149.48万
-
财政年份:2023
-
负责人:Eugene Krentsel
-
依托单位:
I-RED Southeast XLerator Network
-
批准号:10546610
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2022
-
负责人:Eugene Krentsel
-
依托单位:
I-RED Southeast XLerator Network: Business Fundamentals for Core Facility Directors
-
批准号:10684493
-
项目类别:
-
资助金额:$8.3万
-
财政年份:2022
-
负责人:Eugene Krentsel
-
依托单位:
海外基金